IATA and Pharma.Aero join forces to elevate pharmaceutical handling standards

Wednesday, March 13, 2024

The collaboration between the International Air Transport Association (IATA) and Pharma.Aero is focused on enhancing the effectiveness of the IATA Certification for Excellence in Pharmaceutical Handling (CEIV Pharma) program, a globally recognized standard for handling pharmaceutical products.

Over a two-year period, both organizations conducted a thorough analysis of the CEIV Pharma program involving certified entities, pharmaceutical manufacturers, and air logistics professionals. The findings from this extensive study were compiled into a White Paper.

This joint effort revealed several areas for improvement within the program, including:

1. Increasing awareness: Promoting greater interaction with regulatory bodies to ensure the continuous integration of global best practices into the program.
2. Continuous improvement of the certification process: Refining training modules, optimizing checklist formats, and enhancing qualifications for Independent Validators to establish a solid foundation for the program’s ongoing development.
3. Enhancing the visibility of IATA CEIV Pharma within the life science manufacturing sector.
4. Broadening the network to make the program more accessible to smaller businesses and underserved markets.
5. Strengthening IATA ONE Source, an industry platform providing verified aviation capability and infrastructure information, to enable smooth integration with other platforms.

“The CEIV Pharma program is a trusted mark of quality and excellence in the handling of pharmaceuticals, with hundreds of companies globally across the supply chain, including airlines, ground handling service providers and freight forwarders, achieving certification. This initiative between Pharma.Aero and IATA underscores the continuous commitment to not just maintain but elevate CEIV Pharma certification. Extensive dialogue with stakeholders has been instrumental in new identifying opportunities for the program such as reaching smaller enterprises and better serving underserved markets as well as process enhancements,” said Frédéric Léger IATA Senior Vice President of Commercial Products and Services.

Trevor Caswell, Chairman of Pharma.Aero, lauded the collective efforts of Pharma.Aero members participating in the 2-year project. “As a leading advocate for excellence in pharmaceutical logistics, Pharma.Aero leverages the collective expertise of our global community to drive innovation and best practices in the industry. We commend all our members for their time and dedication to this project. Their contributions were decisive in getting first-hand experiences to accurately assess the CEIV Pharma certification and identify opportunities for enhancement”, said Caswell. “Together, as Pharma.Aero, we are driving positive change in pharmaceutical logistics to better serve the needs of patients globally”, concluded Trevor Caswell.

« Back to Page

• International Air Transport Association Urges Pakistan and Bangladesh to Unlock Airlines $720M Revenue

• International Air Transport Association and Partners Compare Aviation Net Zero Roadmaps

• Hong Kong International Airport Crowned World Busiest Cargo Hub for 2023

• International Air Transport Association Spotlights Sustainable Regional Travel

• Riyadh Prepares to Welcome Aviation Experts for Future Aviation Forum 2024